Restoration using DRug for targeting Unbalanced Gene
Prediction of effect complementation (anti-symmetricity) of drug and cancer using transcriptome.
Scoring relationship between gene expression and prognosis by cancer type.
Companion diagnostic biomarker
Mining diagnostic prognostic biomarkers for distinguishing drug-reactive and non-reactive cancer type, and increasing success rate for clinical trials.
Oncocross AI platform identifies the optimal disease indications and drugs.